Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Multiple vertebral fractures sustained 5 months after Roux-en-Y gastric bypass: a case report.

Higgins SC, Papasavvas G.

Arch Osteoporos. 2018 May 2;13(1):51. doi: 10.1007/s11657-018-0471-3.

PMID:
29721620
2.

Measuring hand grip strength in rheumatoid arthritis.

Higgins SC, Adams J, Hughes R.

Rheumatol Int. 2018 May;38(5):707-714. doi: 10.1007/s00296-018-4024-2. Epub 2018 Apr 6. Review.

PMID:
29626222
3.

Respiratory infection with a bacterial pathogen attenuates CNS autoimmunity through IL-10 induction.

Edwards SC, Higgins SC, Mills KHG.

Brain Behav Immun. 2015 Nov;50:41-46. doi: 10.1016/j.bbi.2015.06.009. Epub 2015 Jun 19.

PMID:
26100487
4.

Identification and functional prediction of mitochondrial complex III and IV mutations associated with glioblastoma.

Lloyd RE, Keatley K, Littlewood DT, Meunier B, Holt WV, An Q, Higgins SC, Polyzoidis S, Stephenson KF, Ashkan K, Fillmore HL, Pilkington GJ, McGeehan JE.

Neuro Oncol. 2015 Jul;17(7):942-52. doi: 10.1093/neuonc/nov020. Epub 2015 Mar 2.

5.

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, Núñez G, Latz E, Kastner DL, Mills KH, Masters SL, Schroder K, Cooper MA, O'Neill LA.

Nat Med. 2015 Mar;21(3):248-55. doi: 10.1038/nm.3806. Epub 2015 Feb 16.

6.

Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro.

Higgins SC, Fillmore HL, Ashkan K, Butt AM, Pilkington GJ.

Anticancer Res. 2015 Jan;35(1):77-84.

PMID:
25550537
7.

Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors.

Higgins SC, Bolteus AJ, Donovan LK, Hasegawa H, Doey L, Al Sarraj S, King A, Ashkan K, Roncaroli F, Fillmore HL, Pilkington GJ.

Anticancer Res. 2014 Dec;34(12):6919-24.

PMID:
25503117
8.

A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.

Dunne A, Mielke LA, Allen AC, Sutton CE, Higgs R, Cunningham CC, Higgins SC, Mills KH.

Mucosal Immunol. 2015 May;8(3):607-17. doi: 10.1038/mi.2014.93. Epub 2014 Oct 15.

PMID:
25315966
9.

Conjugated linoleic acid suppresses dendritic cell activation and subsequent Th17 responses.

Draper E, DeCourcey J, Higgins SC, Canavan M, McEvoy F, Lynch M, Keogh B, Reynolds C, Roche HM, Mills KH, Loscher CE.

J Nutr Biochem. 2014 Jul;25(7):741-9. doi: 10.1016/j.jnutbio.2014.03.004. Epub 2014 Mar 27.

PMID:
24794016
10.

Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice.

McManus RM, Higgins SC, Mills KH, Lynch MA.

Neurobiol Aging. 2014 Jan;35(1):109-21. doi: 10.1016/j.neurobiolaging.2013.07.025. Epub 2013 Aug 29.

PMID:
23993702
11.

Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells.

Galvin KC, Dyck L, Marshall NA, Stefanska AM, Walsh KP, Moran B, Higgins SC, Dungan LS, Mills KH.

Cancer Immunol Immunother. 2013 Jul;62(7):1273-82. doi: 10.1007/s00262-013-1432-8. Epub 2013 May 9.

PMID:
23657628
12.

Immunity to the respiratory pathogen Bordetella pertussis.

Higgs R, Higgins SC, Ross PJ, Mills KH.

Mucosal Immunol. 2012 Sep;5(5):485-500. doi: 10.1038/mi.2012.54. Epub 2012 Jun 20. Review.

PMID:
22718262
13.

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.

Conroy H, Galvin KC, Higgins SC, Mills KH.

Cancer Immunol Immunother. 2012 Mar;61(3):425-31. doi: 10.1007/s00262-011-1188-y. Epub 2011 Dec 23.

PMID:
22193988
14.

A deep rough type structure in Bordetella bronchiseptica lipopolysaccharide modulates host immune responses.

Sisti F, Fernández J, Higgins SC, Casabuono A, Couto A, Mills KH, Hozbor D.

Microbiol Immunol. 2011 Dec;55(12):847-54. doi: 10.1111/j.1348-0421.2011.00395.x.

15.

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells.

Sweeney CM, Lonergan R, Basdeo SA, Kinsella K, Dungan LS, Higgins SC, Kelly PJ, Costelloe L, Tubridy N, Mills KH, Fletcher JM.

Brain Behav Immun. 2011 Aug;25(6):1170-81. doi: 10.1016/j.bbi.2011.03.007. Epub 2011 Mar 21.

PMID:
21420486
16.

TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants.

Higgins SC, Mills KH.

Curr Infect Dis Rep. 2010 Jan;12(1):4-12. doi: 10.1007/s11908-009-0080-9.

PMID:
21308494
17.

Human, mouse or rat? Species authentication of glioma-derived cell cultures.

Higgins SC, Steingrimsdottir H, Pilkington GJ.

J Neurosci Methods. 2010 Dec 15;194(1):139-43. doi: 10.1016/j.jneumeth.2010.10.002. Epub 2010 Oct 14.

PMID:
20951163
18.

The role of regulatory T cells in respiratory infections and allergy and asthma.

McGuirk P, Higgins SC, Mills KH.

Curr Allergy Asthma Rep. 2010 Jan;10(1):21-8. doi: 10.1007/s11882-009-0078-2. Review.

PMID:
20425510
19.

The in vitro effects of tricyclic drugs and dexamethasone on cellular respiration of malignant glioma.

Higgins SC, Pilkington GJ.

Anticancer Res. 2010 Feb;30(2):391-7.

PMID:
20332444
20.

Unexpected vomiting in a woman contemplating a second course of chemotherapy for carcinosarcoma of the uterus.

Higgins SC, Zakashansky K, Bovbjerg DH, Hagopian G.

J Pain Symptom Manage. 2008 Aug;36(2):e1-2. doi: 10.1016/j.jpainsymman.2008.02.005. No abstract available.

PMID:
18655951
21.

Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma.

Toomey D, Conroy H, Jarnicki AG, Higgins SC, Sutton C, Mills KH.

Vaccine. 2008 Jun 25;26(27-28):3540-9. doi: 10.1016/j.vaccine.2008.04.005. Epub 2008 Apr 24.

PMID:
18479787
22.

Effect of pretreatment distress on daily fatigue after chemotherapy for breast cancer.

Higgins SC, Montgomery GH, Raptis G, Bovbjerg DH.

J Oncol Pract. 2008 Mar;4(2):59-63. doi: 10.1200/JOP.0822002.

23.

Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Fennelly NK, Sisti F, Higgins SC, Ross PJ, van der Heide H, Mooi FR, Boyd A, Mills KH.

Infect Immun. 2008 Mar;76(3):1257-66. doi: 10.1128/IAI.00836-07. Epub 2008 Jan 14.

24.

Ghrelin, the peripheral hunger hormone.

Higgins SC, Gueorguiev M, Korbonits M.

Ann Med. 2007;39(2):116-36. Review.

PMID:
17453675
25.

TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

Higgins SC, Jarnicki AG, Lavelle EC, Mills KH.

J Immunol. 2006 Dec 1;177(11):7980-9.

26.

Distress before chemotherapy predicts delayed but not acute nausea.

Higgins SC, Montgomery GH, Bovbjerg DH.

Support Care Cancer. 2007 Feb;15(2):171-7. Epub 2006 Aug 3.

PMID:
16896879
27.

Interaction of air ions and bactericidal vapours to control micro-organisms.

Gaunt LF, Higgins SC, Hughes JF.

J Appl Microbiol. 2005;99(6):1324-9.

28.

Regulatory cells and the control of respiratory infection.

McGuirk P, Higgins SC, Mills KH.

Curr Allergy Asthma Rep. 2005 Jan;5(1):51-5. Review.

PMID:
15659263
29.

Electrogastrographic biofeedback: a technique for enhancing normal gastric activity.

Stern RM, Vitellaro K, Thomas M, Higgins SC, Koch KL.

Neurogastroenterol Motil. 2004 Dec;16(6):753-7.

PMID:
15601425
30.

Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent.

Lavelle EC, Jarnicki A, McNeela E, Armstrong ME, Higgins SC, Leavy O, Mills KH.

J Leukoc Biol. 2004 May;75(5):756-63. Epub 2004 Jan 2. Review.

PMID:
14704372
31.

Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, Byrne P, O'Gorman B, Jarnicki A, McGuirk P, Mills KH.

J Immunol. 2003 Sep 15;171(6):3119-27.

32.

Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation.

Lavelle EC, McNeela E, Armstrong ME, Leavy O, Higgins SC, Mills KH.

J Immunol. 2003 Sep 1;171(5):2384-92.

Supplemental Content

Loading ...
Support Center